CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to INCY

BCR-ABL Tyrosine Kinase Inhibitor (TKI)

Phase 2
Incyte Corporation (INCY)

Phase 2

Development Phase

0

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

No Catalysts Found

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Chronic Phase Chronic Myeloid Leukemia

View Full Landscape
Drug Information

Target Indication

Chronic Phase Chronic Myeloid Leukemia

Clinical Trial

NCT03610971

Last updated: 10/24/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.